REQUEST A DEMO
Total
USD $0.00
Search more companies

Orrego Jaramillo Sandra Milena (Colombia)

Main Activities: Pharmaceutical Preparation Manufacturing
Secondary Activities: All Other Miscellaneous Food Manufacturing | Supermarkets and Other Grocery (except Convenience) Stores | Pharmacies and Drug Stores
Full name: Orrego Jaramillo Sandra Milena Profile Updated: May 07, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Spanish Download a sample report

Orrego Jaramillo Sandra Milena is based in Colombia. The head office is in Cali. It operates in the Pharmaceutical Preparation Manufacturing industry. The enterprise was incorporated on January 22, 2010. 5 (2023) employees currently work for Orrego Jaramillo Sandra Milena. From the latest financial highlights, Orrego Jaramillo Sandra Milena reported a net sales revenue drop of 84.89% in 2022. During that time, Orrego Jaramillo Sandra Milena’s total assets decreased by 11.61%. The enterprise’s net profit margin decreased by 3.13% in 2022.

Headquarters
Cl 17 # 38 A27 - 25
Cali; Valle del Cauca;

Contact Details: Purchase the Orrego Jaramillo Sandra Milena report to view the information.

Basic Information
Total Employees:
Purchase the Orrego Jaramillo Sandra Milena report to view the information.
Outstanding Shares:
Purchase the Orrego Jaramillo Sandra Milena report to view the information.
Incorporation Date:
January 22, 2010
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Orrego Jaramillo Sandra Milena report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
-84.89%
Total operating revenue
-84.89%
Operating profit (EBIT)
-79.2%
Net Profit (Loss) for the Period
-93.18%
Total assets
-11.61%
Total equity
-34.5%
Operating Profit Margin (ROS)
5.01%
Net Profit Margin
-3.13%
Return on Equity (ROE)
-14.42%
Quick Ratio
74.66%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?